1. Allergan offloads two drugs to secure approval for merger with AbbVie — How the China coronavirus could threaten pharma's ingredient sourcing — AstraZeneca sees good results in gastric cancer and stroke studies — See more on our front page news TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Abandon Ship...?

Discussion in 'Santarus' started by Anonymous, May 13, 2014 at 2:01 AM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    Now that the transition from Santarus to Salix has been complete for going on five months now, what are the thoughts of those that were not retained vs those that were transferred over to Salix? The horror stories keep pouring in about all the micromanaging taking place at Salix. Rumor has it that over 30% of those retained by Salix have already quit. Is that accurate?
     

  2. Anonymous

    Anonymous Guest

    Hopefully more quit- not many of the Santuarus folks are up to par. Good people but just not a good fit in a performance based company.
     
  3. Anonymous

    Anonymous Guest

    "Performance based"? Laughing my ass off at that one.

    Can't wait until the DOJ wails down the hammer on those Salix idiots.
     
  4. Anonymous

    Anonymous Guest


    Sounds like Salix HR is doing some additional detective work - can't believe the feedback from the exit interviews, huh?
     
  5. Anonymous

    Anonymous Guest

    It is performance based. Too bad it's a vaudeville performance. Bring in the clowns!